Transfusion, 2023 We aimed to summarize the laboratory findings and clinical features of hemolytic disease of the fetus and newborn (HDFN).
Yanjing He, Yang Li, Qiushi Wang
exaly +2 more sources
Neonatal management and outcome in alloimmune hemolytic disease
Expert Review of Hematology, 2017 Introduction: Hemolytic disease of the fetus and newborn (HDFN) occurs when fetal and neonatal erythroid cells are destroyed by maternal erythrocyte alloantibodies, it leads to anemia and hydrops in the fetus, and hyperbilirubinemia and kernicterus in ...
Isabelle M C Ree +2 more
exaly +2 more sources
Patient-Reported Disease Presentation, Interventions, and Outcomes in United States Pregnancies Affected by Alloimmunization at Risk of Hemolytic Disease of the Fetus and Newborn [PDF]
ChildrenBackground/Objectives: Pregnancies complicated by red cell alloimmunization can progress to hemolytic disease of the fetus and newborn (HDFN), requiring close monitoring and timely intervention to prevent fetal/neonatal morbidity and mortality.
Molly R. Sherwood +3 more
doaj +2 more sources
American Journal of Obstetrics and Gynecology, 2018 BACKGROUND: There is controversy on critical cut‐off values of laboratory testing to select pregnancies at increased risk for anti‐Kell‐mediated hemolytic disease of the fetus and newborn.
Yolentha M Slootweg +2 more
exaly +2 more sources
Expert Review of Hematology, 2017 Introduction: Hemolytic disease of the fetus and newborn (HDFN) remains a serious pregnancy complication which can lead to severe fetal anemia, hydrops and perinatal death. Areas covered: This review focusses on the current prenatal management, treatment
Carolien Zwiers +2 more
exaly +2 more sources
Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunizationAJOG Global Reports at a Glance [PDF]
AJOG Global ReportsBACKGROUND: Clinical manifestations of hemolytic disease of the fetus and newborn include anemia, hyperbilirubinemia, hydrops fetalis, kernicterus, and fetal or neonatal demise.
Alexis A. Krumme, ScD +6 more
doaj +2 more sources
Neonatal Jka hemolytic disease combined with alloimmune thrombocytopenia with extreme anemia: a case report with literature review [PDF]
BMC PediatricsBackground Only isolated occurrences of neonatal Jka hemolytic disease have been identified, and no cases of Jka hemolytic disease combining fetal and neonatal alloimmune thrombocytopenia (FNAIT) have been reported.
Fangmei Luo +3 more
doaj +2 more sources
Obstetric aspects of hemolytic disease of the newborn with ABO-isoimmunization [PDF]
Гинекология, 2021 Background. Currently the problem of immunological conflict, due to incompatibility in the ABO system and the development of hemolytic disease (HD) of the newborn, does not lose its relevance.
Iuliia A. Dudareva +2 more
doaj +1 more source
Hemolytic disease of the newborn, beyond the Rhesus disease [PDF]
Romanian Medical Journal, 2022 Hemolytic disease of the fetus and newborn is a consequence of maternal immune response to fetal red blood cells antigens inherited from the father, that the mother does not possess, stimulated by antepartum or intrapartum fetomaternal hemorrhage.
Ana Maria Huszti +4 more
doaj +1 more source
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape
BMC Pregnancy and Childbirth, 2023 Background Prevention of pregnancy-related alloimmunization and the management of hemolytic disease of the fetus and newborn (HDFN) has significantly improved over the past decades. Considering improvements in HDFN care, the objectives of this systematic
D. D. de Winter +3 more
semanticscholar +1 more source